Browse all products for Ubiquitin and Ubl research
Ubiquitin & Ubl Signaling Catalog
Ubiquitinylation of cellular proteins is a highly complex and tightly regulated process that targets, in a specific manner, thousands of cellular proteins. It is carried out by a modular cascade of enzymes with high specificity towards target proteins. Conjugation of ubiquitin can serve a variety of non-proteolytic functions, including activation of enzymes, modulation of membrane dynamics, or routing of the tagged proteins to their sub-cellular destination (Figure 1).

The attachment of ubiquitin to the ε-amino of lysine residues of target proteins requires a series of ATP-dependent enzymatic steps by ubiquitin activating (E1), ubiquitin conjugating (E2) and ubiquitin ligating (E3) enzymes. Consequently, protein ubiquitinylation is achieved through a minimum of three enzymatic steps. In the first step, in an ATP-dependent process, a ubiquitin-activating enzyme (E1) catalyzes the formation of a reactive thioester bond with ubiquitin. This is followed by its subsequent transfer to the active site cysteine of a ubiquitin carrier protein (E2). The specificity of ubiquitin ligation arises from the subsequent association of the E2-ubiquitin thioester with a substrate-specific ubiquitin:protein isopeptide ligase (E3), which facilitates the formation of the isopeptide linkage between ubiquitin and its target protein. (Figure 2).

A small protein of only seventy six amino acids and a molecular weight of ~8.6kDa, ubiquitin (Figure 3) is widely distributed and highly conserved across phylogeny. Ubiquitin contains seven internal lysine residues and terminates with a C-terminal glycyl-glycine motif. It is through this C-terminal glycine residue that ubiquitin attaches itself to the ε-amino group of the side chain of lysine residues within substrate proteins via the formation of an isopeptide bond. In this way, ubiquitin may attach itself as a monomer (mono-ubiquitinylation), as a multiple monomer (multiubiquitinylation), or by internal extension as a polymer (polyubiquitinylation) (Figure 4). The fate of the modified substrate protein will depend upon the exact nature and extent of the modification.


There are at least 10 conjugatable ‘cousins’ of ubiquitin including, amongst others, SUMO, NEDD8, ISG15 and FAT10. These ubiquitin-like proteins (Ubls) can be covalently attached to target proteins for a variety of signalling processes in the cell and may function as critical regulators of many cellular processes, including transcription, DNA repair, signal transduction, autophagy, and cell-cycle control. There is a growing body of data implicating the dysregulation of Ubl-substrate modification and mutations in the Ubl-conjugation machinery in the etiology and progression of a number of human diseases.